Drug Database
Back to search

Netherlands· NL-8b2c32bd4b2f

Kovaltry 2000 IE, poeder en oplosmiddel voor oplossing voor injectie

A coagulation factor viii product containing factor viii, rdna humaan coagulatiefactor viii, sucrose geformuleerd (rfviii-fs)(bayer), registered in Netherlands by Bayer AG. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedKovaltry 2000 IE, poeder en oplosmidd…ATCB02BD02REGISTER NO.NL-8b2c32bd4b2fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about factor viii, rdna humaan coagulatiefactor viii, sucrose geformuleerd (rfviii-fs)(bayer)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Coagulation factor viii is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD02 (coagulation factor viii), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search coagulation factor viii products by name

Coagulation factor viii · ATC B02BD02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FACTOR VIII, rDNA HUMAAN COAGULATIEFACTOR VIII, SUCROSE GEFORMULEERD (rFVIII-FS)(Bayer)
Manufacturer
Bayer AG
Country
Netherlands (NL)
ATC code
B02BD02
ATC class
Coagulation factor VIII
Defined daily dose
1 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/15/1076

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for coagulation factor viii.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check coagulation factor viii against other medicinesHow interaction checks work

Coagulation factor viii · interactions on record

4 records

  • 2 severe
  • 2 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • PegvaliaseA16AB19moderate
  • EmicizumabB02BX06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B02BD02

Coagulation factor viii, as other registers publish it.

All coagulation factor viii products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/debafa40-8fc7-4a16-9037-db706f7885f6
GET /v1/drugs/debafa40-8fc7-4a16-9037-db706f7885f6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/kovaltry-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Coagulation Factor VIII",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp116743",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "GLYCINE (E 640)",
    "HISTIDINE, (L-)",
    "NATRIUMCHLORIDE",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "FACTOR VIII, rDNA HUMAAN COAGULATIEFACTOR VIII, SUCROSE GEFORMULEERD (rFVIII-FS)(Bayer)"
  ],
  "leaflet_url": null,
  "authorised_at": "2016/02/18",
  "procedure_number": "EMEA/H/C/003825",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/15/1076",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about coagulation factor viii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console